News & Updates

Extreme rainfall puts people’s lives at risk

29 Oct 2024 by

Intense rainfall appears to contribute to a higher risk of death from all causes and cardiovascular or respiratory causes, suggests a study. This association varies with local climate and urban infrastructure.

Extreme rainfall puts people’s lives at risk

29 Oct 2024

Happiness is key to a healthy heart

29 Oct 2024 by

An analysis using the UK Biobank dataset shows a robust inverse association between well-being and risk of cardiovascular diseases (CVDs), underpinning the protective effect of higher well-being on the four major CVDs evaluated: coronary heart disease, MI, heart failure (HF), and stroke.

Happiness is key to a healthy heart

29 Oct 2024

Insulin resistance linked to future hypertension in normotensive salt-sensitive individuals

28 Oct 2024

A 10-year study has found the association of salt sensitivity with insulin resistance and endothelial dysfunction in the offspring of hypertensive salt-sensitive parents, making them susceptible to developing hypertension.

Insulin resistance linked to future hypertension in normotensive salt-sensitive individuals

28 Oct 2024

PM2.5 exposure linked to elevated BP

28 Oct 2024

People with long-term exposure to PM2.5 and its chemical constituents appear to be at greater risk for elevated blood pressure (BP), suggests a study.

PM2.5 exposure linked to elevated BP

28 Oct 2024

New gout diagnosis raises cardiovascular risk in the short term

27 Oct 2024

Individuals who have recently received a diagnosis of gout face an increased risk of cardiovascular events within 30 days of the index diagnosis, according to a study.

New gout diagnosis raises cardiovascular risk in the short term

27 Oct 2024

Prehospital glucocorticoid of no help in STEMI patients

25 Oct 2024

Treatment with prehospital pulse-dose glucocorticoid does not appear to shrink final infarct size in patients with ST-segment elevation myocardial infarction (STEMI) after 3 months, according to a study.

Prehospital glucocorticoid of no help in STEMI patients

25 Oct 2024

Long-term single antiplatelet therapy for East Asian patients after PCI

25 Oct 2024 by

Patients presenting with acute coronary syndrome (ACS) often require percutaneous coronary intervention (PCI) to restore cardiac function, and those with chronic coronary syndrome (CCS) may also be treated with PCI to improve clinical outcomes. After PCI, antiplatelet therapy is indicated to prevent future ischaemic events. However, it may increase the risk of bleeding. In an interview with MIMS Doctor, Dr Tat-Chi Leung, Specialist in Cardiology in Hong Kong, and Professor Hyo-Soo Kim from the Seoul National University College of Medicine, South Korea, discussed strategies to improve cardiovascular (CV) outcomes and reduce bleeding complications with antiplatelet therapy, particularly clopidogrel, in East Asian patients with ACS or CCS, including those in Hong Kong.

Long-term single antiplatelet therapy for East Asian patients after PCI

25 Oct 2024

Abbreviated DAPT strategy in an NSTE-ACS patient

25 Oct 2024 by

A 70-year-old man presented to our hospital in April 2023 with intermittent chest pain and shortness of breath of 7 days’ duration. He was a smoker with multiple comorbidities, including hypertension, diabetes mellitus (DM), hyperlipidaemia, ischaemic heart disease and history of peptic ulcer, for which he was receiving amlodipine 5 mg QD, metformin 500 mg BID, atorvastatin 40 mg QD, aspirin 80 mg QD, and pantoprazole 40 mg QD, respectively. He had a CT coronary angiogram in 2018 and it showed mild stenosis in the left anterior descending (LAD) artery, which was managed with aspirin 80 mg QD. The patient developed a haemorrhagic peptic ulcer associated with aspirin use in June 2021. After stabilizing the condition with pantoprazole and blood transfusion, a repeated oesophagogastroduodenoscopy (OGD) was performed, showing resolution of the ulcer. Aspirin treatment was continued along with pantoprazole.

Abbreviated DAPT strategy in an NSTE-ACS patient

25 Oct 2024

Verinurad–allopurinol combo disappoints in HFpEF

24 Oct 2024

Combining verinurad with allopurinol does not appear to boost oxygen uptake or improve symptoms in heart failure with preserved ejection fraction (HFpEF), despite yielding significant reductions in serum uric acid (SUA) levels, according to a phase II study.

Verinurad–allopurinol combo disappoints in HFpEF

24 Oct 2024

Semaglutide helps prevent HF events, CV death in diabetic patients with CKD

24 Oct 2024 by

Treatment with semaglutide can significantly lower the risk of time to first heart failure (HF) events or cardiovascular (CV) death in type 2 diabetes (T2D) patients with chronic kidney disease (CKD), a recent study has shown.

Semaglutide helps prevent HF events, CV death in diabetic patients with CKD

24 Oct 2024

News & Updates

Filter by Specialty:

Specialty:

Extreme rainfall puts people’s lives at risk

Extreme rainfall puts people’s lives at risk

Happiness is key to a healthy heart

Happiness is key to a healthy heart

Insulin resistance linked to future hypertension in normotensive salt-sensitive individuals

Insulin resistance linked to future hypertension in normotensive salt-sensitive individuals

PM2.5 exposure linked to elevated BP

PM2.5 exposure linked to elevated BP

New gout diagnosis raises cardiovascular risk in the short term

New gout diagnosis raises cardiovascular risk in the short term

Prehospital glucocorticoid of no help in STEMI patients

Prehospital glucocorticoid of no help in STEMI patients

Long-term single antiplatelet therapy for East Asian patients after PCI

Long-term single antiplatelet therapy for East Asian patients after PCI

Abbreviated DAPT strategy in an NSTE-ACS patient

Abbreviated DAPT strategy in an NSTE-ACS patient

Verinurad–allopurinol combo disappoints in HFpEF

Verinurad–allopurinol combo disappoints in HFpEF

Semaglutide helps prevent HF events, CV death in diabetic patients with CKD

Semaglutide helps prevent HF events, CV death in diabetic patients with CKD